Furthermore, dmrFABP5, a recombinant FABP5 inhibitor, demonstrated similar outcomes by altering the protein to prevent fatty acid binding, thereby reducing the proliferation, migration, and metastasis of PCa cells [54]. The gene discussed is FABP5; the disease is posterior cortical atrophy.